Tech Company Financing Transactions

Resolution Therapeutics Funding Round

On 10/3/2024, Resolution Therapeutics landed $83.4 million in Series B funding from Syncona and private investors.

Transaction Overview

Announced On
10/3/2024
Transaction Type
Venture Equity
Amount
$83,400,000
Round
Series B
Investors

Syncona (Lead Investor)

Proceeds Purpose
The company intends to use the funds to advance its lead candidate, RTX001, an autologous, engineered, pro-regenerative macrophage cell therapy specifically designed to deliver transformative outcomes in patients with end-stage liver disease.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Centre for Regenerative Medicine, University of Edinburgh, 5
Edinburgh, EH16 4UU
UK
Phone
Undisclosed
Email Address
Overview
Our Vision: Unlocking the regenerative potential of macrophage therapy for the treatment of inflammatory and fibrotic diseases. Our initial focus is in end-stage liver disease. It is the only chronic disease still on the rise in western countries, and affects millions of people worldwide. Unfortunately, only supportive therapies are currently available.
Profile
Resolution Therapeutics LinkedIn Company Profile
Social Media
Resolution Therapeutics Company Twitter Account
Company News
Resolution Therapeutics News
Facebook
Resolution Therapeutics on Facebook
YouTube
Resolution Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Amir Hefni
  Amir Hefni LinkedIn Profile  Amir Hefni Twitter Account  Amir Hefni News  Amir Hefni on Facebook
Chief Financial Officer
Simon Ramsden
  Simon Ramsden LinkedIn Profile  Simon Ramsden Twitter Account  Simon Ramsden News  Simon Ramsden on Facebook
Chief Medical Officer
Cliff Brass
  Cliff Brass LinkedIn Profile  Cliff Brass Twitter Account  Cliff Brass News  Cliff Brass on Facebook
Chief Technical Officer
Amol Ketkar
  Amol Ketkar LinkedIn Profile  Amol Ketkar Twitter Account  Amol Ketkar News  Amol Ketkar on Facebook
Vice President
Eli Gilsohn
  Eli Gilsohn LinkedIn Profile  Eli Gilsohn Twitter Account  Eli Gilsohn News  Eli Gilsohn on Facebook
VP - Human Resources
Shazia Rahman
  Shazia Rahman LinkedIn Profile  Shazia Rahman Twitter Account  Shazia Rahman News  Shazia Rahman on Facebook
VP - Operations
Victor Dillard
  Victor Dillard LinkedIn Profile  Victor Dillard Twitter Account  Victor Dillard News  Victor Dillard on Facebook
VP - R & D
Lara Campana
  Lara Campana LinkedIn Profile  Lara Campana Twitter Account  Lara Campana News  Lara Campana on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/3/2024: Truely venture capital transaction
Next: 10/3/2024: Kubus venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary